Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioEnterprise ValueInvested Capital

Mesoblast (MESO) Equity Average (2018 - 2022)

Mesoblast's Equity Average history spans 5 years, with the latest figure at $539.2 million for Q2 2022.

  • For Q2 2022, Equity Average fell 4.62% year-over-year to $539.2 million; the TTM value through Jun 2022 reached $539.2 million, down 4.62%, while the annual FY2022 figure was $539.2 million, 4.62% down from the prior year.
  • Equity Average for Q2 2022 was $539.2 million at Mesoblast, down from $565.4 million in the prior quarter.
  • Across five years, Equity Average topped out at $565.4 million in Q2 2021 and bottomed at $513.5 million in Q2 2019.
  • The 5-year median for Equity Average is $531.4 million (2018), against an average of $532.9 million.
  • The largest annual shift saw Equity Average rose 9.74% in 2021 before it dropped 4.62% in 2022.
  • A 5-year view of Equity Average shows it stood at $531.4 million in 2018, then decreased by 3.36% to $513.5 million in 2019, then rose by 0.32% to $515.2 million in 2020, then grew by 9.74% to $565.4 million in 2021, then decreased by 4.62% to $539.2 million in 2022.
  • Per Business Quant, the three most recent readings for MESO's Equity Average are $539.2 million (Q2 2022), $565.4 million (Q2 2021), and $515.2 million (Q2 2020).